| Bioactivity | Lefradafiban is an orally active glycoprotein IIb/IIIa receptor antagonist. Lefradafiban can be metabolized to its active form, Fradafiban, a non-peptide GP IIb/IIIa receptor antagonist[1]. |
| CAS | 149503-79-7 |
| Formula | C23H25N3O6 |
| Molar Mass | 439.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Akkerhuis KM, et al. Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty. Heart. 2001 Apr;85(4):444-50. |
Lefradafiban
CAS: 149503-79-7 F: C23H25N3O6 W: 439.46
Lefradafiban is an orally active glycoprotein IIb/IIIa receptor antagonist. Lefradafiban can be metabolized to its activ
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.